Reported Dec 18, 2019 · Terminated
Ranitidine Tablets, USP 150 mg, OTC, a.) 30 count bottle (NDC 68788-7078-03), b.) 60 count bottle (NDC 68788-7078-06),…
Preferred Pharmaceuticals, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Preferred Pharmaceuticals, Inc · 1250 N Lakeview Ave Ste O · Anaheim, CA · 92807-1801
Is this the product you have?
Ranitidine TabletsUSP 150 mgOTCa.) 30 count bottle (NDC 68788-7078-03)b.) 60 count bottle (NDC 68788-7078-06)
- MfgAmneal Pharmaceuticals
- Lot codes and dates
Lot #: I2519HExp. 12/20I2719OExp. 12/20J1419OExp. 12/20J2819LExp. 12/20
- Amount recalled
- 316 bottles
Where it was sold
Why it was recalled
CGMP Deviations: Presence of NDMA impurity detected in product.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Preferred Pharmaceuticals, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.